Anti-CCL4/MIP-1 beta antibody [EP521Y] - BSA and Azide free
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-CCL4/MIP-1 beta antibody [EP521Y] - BSA and Azide free (AB187674)
This data was developed using ab45690, the same antibody clone in a different buffer formulation.
Immunocytochemistry/Immunofluorescence analysis of THP-1 (Human monocytic leukemia cell line) cells labeling CCL4/MIP-1 beta + CCL4L with ab45690 at 1/100. Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. Cells were counter-stained with ab7291, ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at 1/200 dilution. DAPI was used to stain nuclei blue.
The expression increased after treatment with Lipopolysaccharides (LPS), 100 ng/mL for 4 hours, followed by addition of Brefeldin A (1 μg/mL) for 3 hours.
- IP
Lab
Immunoprecipitation - Anti-CCL4/MIP-1 beta antibody [EP521Y] - BSA and Azide free (AB187674)
This data was developed using ab45690, the same antibody clone in a different buffer formulation.
ab45690 at 1/60 immunoprecipitating CCL4/MIP-1 beta + CCL4L in THP-1 (Human monocytic leukemia cell line) whole cell lysate observed at 12 KDa (lanes 1 and 2).
Lane 1 (input) : THP-1 treated with 100 nM PMA overnight, then treated with 100 ng/mL LPS for 7 hours and 1 μg/mL Brefeldin A was added for the last 3 hours whole cell lysate, 10μg.
Lane 2 (+) : ab45690 + THP-1 treated with 100 nM PMA overnight, then treated with 100 ng/mL LPS for 7 hours and 1 μg/mL Brefeldin A was added for the last 3 hours whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab45690 in THP-1 treated with 100 nM PMA overnight, then treated with 100 ng/mL LPS for 7 hours and 1 μg/mL Brefeldin A was added for the last 3 hours whole cell lysate.
For western blotting, ab45690 at 1/1000 and ab131366 VeriBlot for IP Detection Reagent (HRP) was used for detection (1/1000).
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-CCL4/MIP-1 beta antibody [EP521Y] (<a href='/en-us/products/primary-antibodies/ccl4-mip-1-beta-antibody-ep521y-ab45690'>ab45690</a>)
Predicted band size: 10 kDa
false
Exposure time: 3min
- ELISA
Lab
ELISA - Anti-CCL4/MIP-1 beta antibody [EP521Y] - BSA and Azide free (AB187674)
This data was developed using ab45690, the same antibody clone in a different buffer formulation.ELISA analysis of Human CCL4/MIP-1 beta recombinant protein at 500 ng/mL with ab45690. An Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1/2500 dilution was used as the secondary antibody.
- WB
Lab
Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] - BSA and Azide free (AB187674)
This data was developed using ab45690, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
CCL4/MIP-1 beta is induced in macrophages following exposure to bacterial LPS (PMID : 9848081).
All lanes:
Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (<a href='/en-us/products/primary-antibodies/ccl4-mip-1-beta-antibody-ep521y-ab45690'>ab45690</a>) at 1/1000 dilution
Lane 1:
Untreated THP-1 (human acute monocytic leukemia) cell lysate at 10 µg
Lane 2:
THP-1 treated with 100 nM Phorbol-12-myristate-13-acetate(PMA) overnight, then treated with Lipopolysaccharides (LPS) 100 ng/mL for 7 hours and then 1 µg/mL Brefeldin A was added for the last 3 hours, lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 10 kDa
Observed band size: 12 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] - BSA and Azide free (AB187674)
False colour image of Western blot : Anti-CCL4/MIP-1 beta antibody [EP521Y] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab45690 was shown to bind specifically to CCL4/MIP-1 beta. A band was observed at 12 kDa in wild-type THP-1 cell lysates with no signal observed at this size in CCL4 knockout cell line ab273719 (knockout cell lysate ab275512). To generate this image, wild-type and CCL4 knockout THP-1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (<a href='/en-us/products/primary-antibodies/ccl4-mip-1-beta-antibody-ep521y-ab45690'>ab45690</a>) at 1/1000 dilution
Lane 1:
Wild-type THP-1 Vehicle control + Brefeldin A (5 u/mL, 6 h) cell lysate at 20 µg
Lane 2:
Wild-type THP-1 Treated PMA (100 ng/mL, 56 h) + LPS (1 u/mL, 24 h) + Brefeldin A (5 u/mL, 6 h) cell lysate at 20 µg
Lane 2:
Western blot - Human CCL4 knockout THP-1 cell line (<a href='/en-us/products/cell-lines/human-ccl4-knockout-thp-1-cell-line-ab273719'>ab273719</a>)
Lane 3:
CCL4 knockout THP-1 Vehicle control + Brefeldin A (5 u/mL, 6 h) cell lysate at 20 µg
Lane 4:
CCL4 knockout THP-1 Treated PMA (100 ng/mL, 56 h) + LPS (1 u/mL, 24 h) + Brefeldin A (5 u/mL, 6 h) cell lysate at 20 µg
Predicted band size: 10 kDa
Observed band size: 12 kDa
false
- WB
Lab
Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] - BSA and Azide free (AB187674)
This data was developed using ab45690, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (<a href='/en-us/products/primary-antibodies/ccl4-mip-1-beta-antibody-ep521y-ab45690'>ab45690</a>) at 1/1000 dilution
Lane 1:
Untreated Raw264.7 (mouse abelson murine leukemia virus-induced tumor) whole cell lysate at 10 µg
Lane 2:
Raw264.7 (mouse abelson murine leukemia virus-induced tumor) treated with LPS 10μg/mL for 4 hours and then 1 μg/mL Brefeldin A was added for the last 3 hours lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 10 kDa,18 kDa,25 kDa,55 kDa,57 kDa
Observed band size: 12 kDa,18 kDa,26 kDa,90 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] - BSA and Azide free (AB187674)
This data was developed using ab45690, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (<a href='/en-us/products/primary-antibodies/ccl4-mip-1-beta-antibody-ep521y-ab45690'>ab45690</a>) at 1/1000 dilution
Lane 1:
Untagged human CCL4 recombinant protein (aa24-92) at 10 µg
Lane 2:
Untagged human CCL4L recombinant protein (aa24-92) at 10 µg
Lane 3:
GST-tagged human CCL3 recombinant protein (aa27-92) at 10 µg
Lane 4:
GST-tagged human CCL3L recombinant protein 2*(aa28-93) at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 10 kDa
Observed band size: 12 kDa
false
Exposure time: 5s
Related conjugates and formulations (7)
-
Anti-CCL4/MIP-1 beta antibody [EP521Y]
-
660 APC
APC Anti-CCL4/MIP-1 beta antibody [EP521Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CCL4/MIP-1 beta antibody [EP521Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-CCL4/MIP-1 beta antibody [EP521Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CCL4/MIP-1 beta antibody [EP521Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CCL4/MIP-1 beta antibody [EP521Y]
-
578 PE
PE Anti-CCL4/MIP-1 beta antibody [EP521Y]
Reactivity data
Product details
ab187674 is the carrier-free version of ab45690.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CCL4 is critical in immune system modulation. It coordinates leukocyte activation and trafficking contributing to inflammation and immune surveillance. It does not function in isolation but rather interacts with other chemokines and receptors. CCL4 alongside its sibling chemokines forms a dynamic network that ensures a balanced immune response. It connects to receptors such as CCR5 playing substantial roles in its activities.
Pathways
CCL4 participates in essential signaling cascades that mediate immune responses. It is notably part of the chemokine signaling pathway which is instrumental in directing cell movement. CCL4 also engages with proteins like CCR5 in the inflammatory and immune response pathways. This interaction enhances communication between cells required for effective pathogen defense.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Alternative Names
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:9035 PubMed41073433
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com